Regen Therapeutics PLC - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Regen Therapeutics PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Regen Therapeutics PLC. The Group's principal activities are developing drug and providing ancillary services. It also conducts pharmacokinetic and pharmacodynamic research. Its operation focuses on the research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex derived from ovine and bovine colostrum. The Group operates solely in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report